Division of Gastroenterology, Department of Internal Medicine, University of Michigan, 1500 East Medical Center Drive, 3912 TC SPC 5362, Ann Arbor, MI 48109, USA.
Division of Gastroenterology, Department of Internal Medicine, University of Michigan, 1500 East Medical Center Drive, 3912 TC SPC 5362, Ann Arbor, MI 48109, USA.
Gastroenterol Clin North Am. 2021 Mar;50(1):183-199. doi: 10.1016/j.gtc.2020.10.002. Epub 2020 Dec 27.
Irritable bowel syndrome (IBS) affects 10% to 15% of the population and often is difficult to treat with available pharmacologic agents. Dietary therapies for IBS are of particular interest because up to 90% of IBS patients exclude certain foods to improve their gastrointestinal symptoms. Among the available dietary interventions for IBS, the low FODMAP diet has the greatest evidence for efficacy. Although dietary therapies rapidly are becoming first-line treatment of IBS, gastroenterologists need to be aware of the negative effects of prescribing restrictive diets and red flag symptoms of maladaptive eating patterns.
肠易激综合征（IBS）影响 10%至 15%的人群，并且通常难以用现有药物治疗。IBS 的饮食疗法特别受到关注，因为多达 90%的 IBS 患者会排除某些食物以改善胃肠道症状。在 IBS 的可用饮食干预措施中，低 FODMAP 饮食的疗效证据最多。尽管饮食疗法迅速成为 IBS 的一线治疗方法，但胃肠病学家需要注意开具限制饮食的负面后果和不良饮食习惯的危险信号。
